Publikationen

Unsere wissenschaftlichen Publikationen zu Transforming Growth Factor-beta (TGF-β) finden Sie hier:

2016

Wosikowski K., Hasenbach, K., Petschenka, J., Barea Roldán, D., Kreiter, S., Sahin, U., Serin, G., Redon, J.O., Hillairet de Boisferon, M., Bichat, F., Korhonen, H., Janicot, M.

Anti-Metastatic Activity of ISTH0047 – a Potent and Selective TGF-β2 Antisense Oligonucleotide - in Syngeneic Lung Metastatic Model of Mouse 4T1 Mammary Carcinoma

AACR Annual Meeting, New Orleans, LA. USA. April 16-20 2016 Anti-Metastatic Activity of ISTH0047 – a Potent and Selective TGF-β2 Antisense Oligonucleotide - in Syngeneic Lung Metastatic Model of Mouse 4T1 Mammary Carcinoma

2015

Wosikowski, K., Hasenbach, K., Allais, L., Fant, P., Bellebeau, F., Truchot, N., Voute, H., Krampert, M., Roehl, I., Vornlocher, HP., Jaschinski, F., Korhonen, H., Vercruysse, K., Fettes, P., Mala, C., Leo, E. and Janicot, M.

Preclinical Profile of ISTH0036, a Potent and Selective Antisense Oligonucleotide Targeting Transforming Growth Factor beta 2 (TGF-β2) for the Treatment of Ophthalmic Diseases

ARVO, Denver, USA, May 7 2015 Preclinical Profile of ISTH0036, a Potent and Selective Antisense Oligonucleotide Targeting Transforming Growth Factor beta 2 (TGF-β2) for the Treatment of Ophthalmic Diseases